NASDAQ:EIKN

Eikon Therapeutics . Common Stock Stock Forecast

etoro logo Buy EIKN
*Your capital is at risk
$9.73
+0.440 (+4.74%)
At Close: Aug 10, 2026

Should you buy EIKN stock?

Last updated:

Based on market data through , StockInvest.us rates Eikon Therapeutics, Inc. Common Stock (EIKN) as a Sell Candidate with a technical score of -1.64 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 9.33%
  • 3-month trend forecast Down 9.97%
  • Sell Candidate -1.64
AI Analysis AI Analysis of EIKN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add EIKN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Monday for Eikon Therapeutics, Inc. Common Stock
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 24, 2026 Gain 9.33%

The Eikon Therapeutics, Inc. Common Stock stock price gained 4.74% on the last trading day (Monday, 10th Aug 2026), rising from $9.29 to $9.73. During the last trading day the stock fluctuated 6.27% from a day low at $9.25 to a day high of $9.83. The price has fallen in 6 of the last 10 days and is down by -1.52% for this period. Volume fell on the last day by -183 thousand shares and in total, 476 thousand shares were bought and sold for approximately $4.63 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.97% during the next 3 months and, with a 90% probability hold a price between $6.71 and $11.19 at the end of this 3-month period.

EIKN Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 24, 2026, and so far it has risen 9.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Eikon Therapeutics, Inc. Common Stock stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $10.24. On a fall, the stock will find some support from the short-term average at $9.39. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Eikon Therapeutics, Inc. Common Stock stock

Eikon Therapeutics, Inc. Common Stock finds support from accumulated volume at $9.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.580 between high and low, or 6.27%. For the last week, the stock has had daily average volatility of 6.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EIKN) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Eikon Therapeutics, Inc. Common Stock to open at $9.60, and during the day (based on 14 day Average True Range), to move between $9.34 and $10.12, which gives a possible trading interval of +/-$0.775 (+/-8.29%) up or down from last closing price. If Eikon Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 8.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $9.62 (1.13%) than the resistance at $9.95 (2.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Eikon Therapeutics, Inc. Common Stock stock A Buy?

Eikon Therapeutics, Inc. Common Stock holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.639 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $9.60 ( 1.30%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

EIKN Performance

Trading levels for EIKN

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 10.18 4.66%
R2 9.96 2.38%
R1 9.82 0.98%
Price 9.73
S1 9.38 -3.58%
S2 9.24 -4.99%
S3 9.02 -7.26%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.75 20.76%
R2 11.45 17.68%
R1 9.95 2.26%
Price 9.73
S1 9.62 -1.13%
S2 9.29 -4.52%
S3 9.21 -5.34%

FAQ

What is the symbol for Eikon Therapeutics, Inc. Common Stock Stock and on which exchange is it traded?
The symbol for Eikon Therapeutics, Inc. Common Stock is EIKN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eikon Therapeutics, Inc. Common Stock Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Eikon Therapeutics, Inc. Common Stock (EIKN) as a Sell Candidate with a technical score of -1.64 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 24, 2026, the price has risen 9.33%. The current 3-month trend forecast projects a fall of 9.97%.

How to buy Eikon Therapeutics, Inc. Common Stock Stock?
Eikon Therapeutics, Inc. Common Stock Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eikon Therapeutics, Inc. Common Stock Stock.

What's the current price of Eikon Therapeutics, Inc. Common Stock Stock?
As of the end of day on the Aug 10, 2026, the price of an Eikon Therapeutics, Inc. Common Stock (EIKN) share was $9.73.

What is the 52-week high and low for Eikon Therapeutics, Inc. Common Stock Stock?
The 52-week high for Eikon Therapeutics, Inc. Common Stock Stock is $17.40 and the 52-week low is $7.90.

What is the market capitalization of Eikon Therapeutics, Inc. Common Stock Stock?
As of the Aug 10, 2026, the market capitalization of Eikon Therapeutics, Inc. Common Stock is 526.769M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE